Association of central serotonin transporter availability and body mass index in healthy Europeans

Swen Hesse, Elsmarieke van de Giessen, Franziska Zientek, David Petroff, Karsten Winter, John C. Dickson, Livia Tossici-Bolt, Terez Sera, Susanne Asenbaum, Jacques Darcourt, Umit O. Akdemir, Gitte M. Knudsen, Flavio Nobili, Marco Pagani, Thierry Vander Borght, Koen Van Laere, Andrea Varrone, Klaus Tatsch, Osama Sabri, Jan Booij

Research output: Contribution to journalArticle

Abstract

Serotonin-mediated mechanisms, in particular via the serotonin transporter (SERT), are thought to have an effect on food intake and play an important role in the pathophysiology of obesity. However, imaging studies that examined the correlation between body mass index (BMI) and SERT are sparse and provided contradictory results. The aim of this study was to further test the association between SERT and BMI in a large cohort of healthy subjects. Methods: 127 subjects of the ENC DAT database (58 females, age 52±18 years, range 20-83, BMI 25.2±3.8kg/m2, range 18.2-41.1) were analysed using region-of-interest (ROI) and voxel-based approaches to calculate [123I]FP-CIT specific-to-nonspecific binding ratios (SBR) in the hypothalamus/thalamus and midbrain/brainstem as SERT-specific target regions. Results: In the voxel-based analysis, SERT availability and BMI were positively associated in the thalamus, but not in the midbrain. In the ROI-analysis, the interaction between gender and BMI showed a trend with higher correlation coefficient for men in the midbrain albeit not significant (0.033SBRm2/kg, p=0.1). Conclusions: The data are in agreement with previous PET findings of an altered central serotonergic tone depending on BMI, as a probable pathophysiologic mechanism in obesity, and should encourage further clinical studies in obesity targeting the serotonergic system.

Original languageEnglish
Pages (from-to)1240-1247
Number of pages8
JournalEuropean Neuropsychopharmacology
Volume24
Issue number8
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Body Mass Index
Mesencephalon
Obesity
Thalamus
Hypothalamus
Brain Stem
Serotonin
Healthy Volunteers
Eating
Databases

Keywords

  • 5-HTT
  • BMI
  • FP-CIT
  • Obesity
  • Serotonin
  • SPECT

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Cite this

Hesse, S., van de Giessen, E., Zientek, F., Petroff, D., Winter, K., Dickson, J. C., ... Booij, J. (2014). Association of central serotonin transporter availability and body mass index in healthy Europeans. European Neuropsychopharmacology, 24(8), 1240-1247. https://doi.org/10.1016/j.euroneuro.2014.05.005

Association of central serotonin transporter availability and body mass index in healthy Europeans. / Hesse, Swen; van de Giessen, Elsmarieke; Zientek, Franziska; Petroff, David; Winter, Karsten; Dickson, John C.; Tossici-Bolt, Livia; Sera, Terez; Asenbaum, Susanne; Darcourt, Jacques; Akdemir, Umit O.; Knudsen, Gitte M.; Nobili, Flavio; Pagani, Marco; Vander Borght, Thierry; Van Laere, Koen; Varrone, Andrea; Tatsch, Klaus; Sabri, Osama; Booij, Jan.

In: European Neuropsychopharmacology, Vol. 24, No. 8, 01.01.2014, p. 1240-1247.

Research output: Contribution to journalArticle

Hesse, S, van de Giessen, E, Zientek, F, Petroff, D, Winter, K, Dickson, JC, Tossici-Bolt, L, Sera, T, Asenbaum, S, Darcourt, J, Akdemir, UO, Knudsen, GM, Nobili, F, Pagani, M, Vander Borght, T, Van Laere, K, Varrone, A, Tatsch, K, Sabri, O & Booij, J 2014, 'Association of central serotonin transporter availability and body mass index in healthy Europeans', European Neuropsychopharmacology, vol. 24, no. 8, pp. 1240-1247. https://doi.org/10.1016/j.euroneuro.2014.05.005
Hesse, Swen ; van de Giessen, Elsmarieke ; Zientek, Franziska ; Petroff, David ; Winter, Karsten ; Dickson, John C. ; Tossici-Bolt, Livia ; Sera, Terez ; Asenbaum, Susanne ; Darcourt, Jacques ; Akdemir, Umit O. ; Knudsen, Gitte M. ; Nobili, Flavio ; Pagani, Marco ; Vander Borght, Thierry ; Van Laere, Koen ; Varrone, Andrea ; Tatsch, Klaus ; Sabri, Osama ; Booij, Jan. / Association of central serotonin transporter availability and body mass index in healthy Europeans. In: European Neuropsychopharmacology. 2014 ; Vol. 24, No. 8. pp. 1240-1247.
@article{f1fa9fb3bdd043c0b0dafa13003da18e,
title = "Association of central serotonin transporter availability and body mass index in healthy Europeans",
abstract = "Serotonin-mediated mechanisms, in particular via the serotonin transporter (SERT), are thought to have an effect on food intake and play an important role in the pathophysiology of obesity. However, imaging studies that examined the correlation between body mass index (BMI) and SERT are sparse and provided contradictory results. The aim of this study was to further test the association between SERT and BMI in a large cohort of healthy subjects. Methods: 127 subjects of the ENC DAT database (58 females, age 52±18 years, range 20-83, BMI 25.2±3.8kg/m2, range 18.2-41.1) were analysed using region-of-interest (ROI) and voxel-based approaches to calculate [123I]FP-CIT specific-to-nonspecific binding ratios (SBR) in the hypothalamus/thalamus and midbrain/brainstem as SERT-specific target regions. Results: In the voxel-based analysis, SERT availability and BMI were positively associated in the thalamus, but not in the midbrain. In the ROI-analysis, the interaction between gender and BMI showed a trend with higher correlation coefficient for men in the midbrain albeit not significant (0.033SBRm2/kg, p=0.1). Conclusions: The data are in agreement with previous PET findings of an altered central serotonergic tone depending on BMI, as a probable pathophysiologic mechanism in obesity, and should encourage further clinical studies in obesity targeting the serotonergic system.",
keywords = "5-HTT, BMI, FP-CIT, Obesity, Serotonin, SPECT",
author = "Swen Hesse and {van de Giessen}, Elsmarieke and Franziska Zientek and David Petroff and Karsten Winter and Dickson, {John C.} and Livia Tossici-Bolt and Terez Sera and Susanne Asenbaum and Jacques Darcourt and Akdemir, {Umit O.} and Knudsen, {Gitte M.} and Flavio Nobili and Marco Pagani and {Vander Borght}, Thierry and {Van Laere}, Koen and Andrea Varrone and Klaus Tatsch and Osama Sabri and Jan Booij",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.euroneuro.2014.05.005",
language = "English",
volume = "24",
pages = "1240--1247",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier Science B.V.",
number = "8",

}

TY - JOUR

T1 - Association of central serotonin transporter availability and body mass index in healthy Europeans

AU - Hesse, Swen

AU - van de Giessen, Elsmarieke

AU - Zientek, Franziska

AU - Petroff, David

AU - Winter, Karsten

AU - Dickson, John C.

AU - Tossici-Bolt, Livia

AU - Sera, Terez

AU - Asenbaum, Susanne

AU - Darcourt, Jacques

AU - Akdemir, Umit O.

AU - Knudsen, Gitte M.

AU - Nobili, Flavio

AU - Pagani, Marco

AU - Vander Borght, Thierry

AU - Van Laere, Koen

AU - Varrone, Andrea

AU - Tatsch, Klaus

AU - Sabri, Osama

AU - Booij, Jan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Serotonin-mediated mechanisms, in particular via the serotonin transporter (SERT), are thought to have an effect on food intake and play an important role in the pathophysiology of obesity. However, imaging studies that examined the correlation between body mass index (BMI) and SERT are sparse and provided contradictory results. The aim of this study was to further test the association between SERT and BMI in a large cohort of healthy subjects. Methods: 127 subjects of the ENC DAT database (58 females, age 52±18 years, range 20-83, BMI 25.2±3.8kg/m2, range 18.2-41.1) were analysed using region-of-interest (ROI) and voxel-based approaches to calculate [123I]FP-CIT specific-to-nonspecific binding ratios (SBR) in the hypothalamus/thalamus and midbrain/brainstem as SERT-specific target regions. Results: In the voxel-based analysis, SERT availability and BMI were positively associated in the thalamus, but not in the midbrain. In the ROI-analysis, the interaction between gender and BMI showed a trend with higher correlation coefficient for men in the midbrain albeit not significant (0.033SBRm2/kg, p=0.1). Conclusions: The data are in agreement with previous PET findings of an altered central serotonergic tone depending on BMI, as a probable pathophysiologic mechanism in obesity, and should encourage further clinical studies in obesity targeting the serotonergic system.

AB - Serotonin-mediated mechanisms, in particular via the serotonin transporter (SERT), are thought to have an effect on food intake and play an important role in the pathophysiology of obesity. However, imaging studies that examined the correlation between body mass index (BMI) and SERT are sparse and provided contradictory results. The aim of this study was to further test the association between SERT and BMI in a large cohort of healthy subjects. Methods: 127 subjects of the ENC DAT database (58 females, age 52±18 years, range 20-83, BMI 25.2±3.8kg/m2, range 18.2-41.1) were analysed using region-of-interest (ROI) and voxel-based approaches to calculate [123I]FP-CIT specific-to-nonspecific binding ratios (SBR) in the hypothalamus/thalamus and midbrain/brainstem as SERT-specific target regions. Results: In the voxel-based analysis, SERT availability and BMI were positively associated in the thalamus, but not in the midbrain. In the ROI-analysis, the interaction between gender and BMI showed a trend with higher correlation coefficient for men in the midbrain albeit not significant (0.033SBRm2/kg, p=0.1). Conclusions: The data are in agreement with previous PET findings of an altered central serotonergic tone depending on BMI, as a probable pathophysiologic mechanism in obesity, and should encourage further clinical studies in obesity targeting the serotonergic system.

KW - 5-HTT

KW - BMI

KW - FP-CIT

KW - Obesity

KW - Serotonin

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=84905041212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905041212&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2014.05.005

DO - 10.1016/j.euroneuro.2014.05.005

M3 - Article

C2 - 24976619

AN - SCOPUS:84905041212

VL - 24

SP - 1240

EP - 1247

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 8

ER -